The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors associated with de novo metastatic colorectal cancer in early onset colorectal cancer.
 
Emma Schatoff
Stock and Other Ownership Interests - Moderna Therapeutics
 
Joanne Chou
Stock and Other Ownership Interests - PAIGE.AI (Inst)
Patents, Royalties, Other Intellectual Property - Company Paige.AI MSK has licensed intellectual property related to digital pathology slides and algorithm development to Paige. MSK also holds equity in Paige. AI. (Inst)
 
Marinela Capanu
No Relationships to Disclose
 
Ramzi Homsi
No Relationships to Disclose
 
Henry Walch
No Relationships to Disclose
 
Randze Lerie Palmaira
No Relationships to Disclose
 
Jill Weiss
No Relationships to Disclose
 
Jordana Kaller
No Relationships to Disclose
 
Callahan Wilde
No Relationships to Disclose
 
Walid Chatila
No Relationships to Disclose
 
Robin Mendelsohn
Consulting or Advisory Role - Exact Sciences
Speakers' Bureau - Medscape
 
Andrea Cercek
Stock and Other Ownership Interests - Haystack Oncology
Consulting or Advisory Role - Abbvie; Agenus; Daiichi Sankyo/Astra Zeneca; G1 Therapeutics; GlaxoSmithKline; Incyte; Janssen; Merck; Regeneron; Roche/Genentech; Seagen
Research Funding - GlaxoSmithKline; Seagen
Patents, Royalties, Other Intellectual Property - Hepatic arterial infusion with FUDR for colorectal liver metastases with DPD (Inst); Hepatic arterial infusion with FUDR for colorectal liver metastases with DPD (Inst); Neoadjuvant PD1 blockade in mismatch repair deficient solid tumors (Inst)